Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2025

Feb 20, 2025

30561_dirs_2025-02-19_b1c6591d-defb-455e-a804-4866766260f0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2025-02-14

Reporting Person: Beckerle Mary C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-14 Common Stock M 8354 $23.24 Acquired 42616 Direct
2025-02-14 Common Stock S 8354 $34.87 Disposed 34262 Direct
2025-02-14 Common Stock S 3856 $34.90 Disposed 30406 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-14 Option (right to buy) $23.24 M 8354 Disposed 2031-01-04 Common Stock (8354) Direct

Footnotes

F1: Includes 30,406 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic
equivalent of one share of Common Stock.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.87 to $34.88. Reporting Person undertakes to provide Exelixis, Inc., any security
holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in
footnote 2 to this Form 4.

F3: The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.